Thursday, September 23, 2021

FDA backs Pfizer COVID-19 boosters for seniors, high-riskFDA backs Pfizer COVID-19 boosters for seniors, high-riskFDA backs Pfizer COVID-19 boosters for seniors, high-risk

FDA backs Pfizer COVID-19 boosters for seniors, high-risk

The uncertainties were yet another reminder that the science surrounding boosters is more complicated than the Biden administration suggested when the president and his top aides rolled out their plan at the White House last month.



from Section Page News - Modern Healthcare https://ift.tt/39xbB3S

No comments:

Post a Comment